An innovative piezoelectric-based method for measuring pulse wave velocity in patients with hypertension

Journal of Clinical Hypertension

Volumn 13, Issue 7, 2011, Pages 497-505

  Murphy, John C ^a   Morrison, Katherine ^a   Mclaughlin, James ^b   Manoharan, Ganesh ^a   Adgey, Aa Jennifer ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; FELODIPINE; HYDROCHLOROTHIAZIDE; IRBESARTAN; LERCANIDIPINE; LISINOPRIL; LOSARTAN; MONOXIDINE; NEBIVOLOL; OLMESARTAN; PERINDOPRIL; POLYVINYLIDENE FLUORIDE; PROPRANOLOL; RAMIPRIL; TRANDOLAPRIL; UNCLASSIFIED DRUG; VALSARTAN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; APPLANATION TONOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BRACHIAL ARTERY; BRACHIAL RADIAL PULSE WAVE VELOCITY; CAROTID ARTERY; CAROTID RADIAL SEGMENT PULSE WAVE VELOCITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESSENTIAL HYPERTENSION; FEMALE; FOREARM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PIEZOELECTRICITY; PRIORITY JOURNAL; PULSE WAVE; RADIAL ARTERY; SPHYGMOMANOMETER; SPHYGMOMANOMETRY; TONOMETRY; TREATMENT INDICATION;

ADULT; AGED; BLOOD FLOW VELOCITY; CAROTID ARTERIES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PATIENT SELECTION; PULSATILE FLOW; REPRODUCIBILITY OF RESULTS; RISK FACTORS; VASCULAR RESISTANCE;

EID: 79960472904     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2011.00433.x     Document Type: Article

References (24)

1. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol. 2003;23:554-566.
2. Simon AC, Levenson J, Bouthier J, et al. Evidence of early degenerative changes in large arteries in human essential hypertension. Hypertension. 1985;7:675-680.
3. London GM, Marchais SJ, Safar ME, et al. Aortic and large artery compliance in end-stage renal failure. Kidney Int. 1990;37:137-142.
4. Arnold JM, Marchiori GE, Imrie JR, et al. Large artery function in patients with chronic heart failure. Studies of brachial artery diameter and haemodynamics. Circulation. 1991;84:2418-2425.
5. Rusak EJ, Bellido CA, Iavicoli OR, et al. Assessment of endothelial function by means of flow-mediated changes using pulse wave velocity. J Clin Hypertens (Greenwich). 2010;12:495-501.
6. McEniery CM, Yasmin, Hall IR, et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity. The Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46:1753-1760.
7. Pannier BM, Safar ME, Laurent S, et al. Indirect, non-invasive evaluation of pressure wave transmission in essential hypertension. Angiology. 1989;40:29-35.
8. Klip W. Difficulties in the measurement of pulse-wave velocity. Am Heart J. 1958;6:806-813.
9. Hickson SK, McSwiney BA. Effect of respiratory movements on PWV. J Physiol. 1924;59:217.
10. Dutch J, Redman S. Psychological stress and arterial pulse transit time. NZ Med J. 1983;96:607-609.
11. Van Bortel LM, Duprez D, Starmans-Kool MJ, et al. Clinical Applications of Arterial Stiffness, Task Force III: recommendations for user procedures. Am J Hypertens. 2002;15:445-452.
12. Asmar RG, Benetos A, Chaouche-Teyara K, et al. Comparison of effects of felodipine versus hydrochlorothiazide on arterial diameter and pulse-wave velocity in essential hypertension. Am J Cardiol. 1993;72:794-798.
13. Asmar RG, Journo HJ, Lacolley PJ, et al. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension. J Hypertens. 1988;6(suppl 3):S33-S39.
14. Vyssoulis GP, Karpanou EA, Kyvelou SM, et al. Beneficial effect of angiotensin II type 1 receptor blocker antihypertensive treatment on arterial stiffness: the role of smoking. J Clin Hypertens (Greenwich). 2008;10:201-207.
15. Komai N, Ohishi M, Moriguchi A, et al. Low-dose doxazosin improved aortic stiffness and endothelial dysfunction as measured by noninvasive evaluation. Hypertens Res. 2002;25:5-10.
16. Davies J, Gavin A, Band M, et al. Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients. Br J Clin Pharmacol. 2005;59:520-523.
17. Asmar R, Hugues C, Pannier B, et al. Duration of action of bisoprolol after cessation of a 4week treatment and its influence on pulse wave velocity and aortic diameter: a pilot study in hypertensive patients. Eur Heart J. 1987;8(suppl M):S115-S120.
18. Wilkinson IB, Fuchs SA, Jansen IM, et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens. 1998;16:2079-2084.
19. McLaughlin J, McNeill M, Braun B, et al. Piezoelectric sensor determination of arterial pulse wave velocity. Physiol Meas. 2003;24:693-702.
20. Asmar R. Arterial Stiffness and Pulse Wave Velocity. Clinical Applications, Elsevier 1999;43.
21. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18:139-185.
22. Armentano R, Simon A, Levenson J, et al. Mechanical pressure versus intrinsic effects of hypertension on large arteries in humans. Hypertension. 1991;18:657-664.
23. Latham RD, Westerhof N, Sipkema P, et al. Regional wave travel and reflections along the human aorta: a study with six simultaneous micromonometric pressures. Circulation. 1985;72:1257-1269.
24. Asmar R. Arterial Stiffness and Pulse Wave Velocity. Clinical Applications, Elsevier 1999:28.